Skip to content

Author

Sheng-Hsiang Lin

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Age-stratified risk of major adverse cardiovascular events with JAK inhibitors in rheumatoid arthritis: A nationwide cohort study.

BACKGROUND The cardiovascular safety of Janus kinase inhibitors (JAKi) compared with biological disease-modifying antirheumatic drugs (bDMARDs) and conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) in rheumatoid arthritis (RA) remains debated. We aimed to evaluate the risk of major adverse cardiov...

Chun-Hsin Wu, Chia-Tse Weng, Sheng-Hsiang Lin · 0 citations
Open access Aug 2026

Sodium-Glucose Cotransporter-2 Inhibition in Patients With Newly Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.

BACKGROUND Sodium-glucose cotransporter-2 (SGLT2) inhibitors reduce incident atrial fibrillation (AF), but their association with cerebrovascular and cardiovascular outcomes after AF diagnosis remains uncertain. We evaluated these outcomes in patients with newly diagnosed AF. METHODS Using Taiwan's National Health In...

Ting-Chun Huang, L. Yap, Hui-Wen Lin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.